The nucleoside antibiotic hikizimycin (C21H37N5O14) inhibits the growth of some bacteria and some fungi. The isolation and characterization2) as well as the partial structure3, 4) of hikizimycin have already been reported. The total structure of the antibiotic5) is now proposed This observation led us to evaluate the effect of hikizimycin on the protein biosynthesis in in vivo and in vitro system.
The present paper describes the effects of hikizimycin on the protein biosynthesis in intact cells of Pseudomonas syringiae and cell-free systems of Escherichia coll.
Materials and Methods
Materials:
Ribosomes and supernatant enzymes (S-100 fraction) from E. coli A19,7) a RNAase I-less mutant, were prepared as described.8) After high-speed centrifugation, a fraction of the uppermost supernatant fluid was dialyzed with 0.01 M tris-HCI buffer (pH 7.6) containing 0.01 M magnesium acetate and 0.006 M 2-mercaptoethanol.
The ribosomes were suspended in 0.01 M magnesium acetate.
For the binding assay ribosomes were washed three times with 0.01 M tris-HCl buffer (pH 7.6) containing 0.01 M magnesium acetate and 0.5 M NH4C1. All collected enzymes and ribosomal particles were kept until use at -65°C.
One A260 unit was taken to represent 25 pmole of 70 S ribosomes.9)
[14C]-Phenylalanyl-tRNA was prepared from E. coli MRE 600 tRNA (Boehringer, Mannheim, Germany) and [14C] -phenylalanine as described.10) The product was treated with acetic anhydride by the method of HAENNI and CHAPEVILLE11) to obtain N-acetyl-[14C]-phenylalanyltRNA. The acetylated preparation was passed through Sephadex G-25 and precipitated.
[14C]-Isoleucine (338 Ci/mole), [14C]-phenylalanine (225 Ci/mole), and [14C]-uracil (62 Ci/mole) were purchased from the Radiochemical Centre, Amersham, England.
Hikizimycin was isolated according to methods described in a previous paper 2) gougerotin was purchased from Calbiochem.
2. Synthesis of cellular macromolecules: Isotopic incorporation studies were performed by addition of 2.5 pCi [14C]_i soleucine or 2.5,U pCi [14C]-uracil to growth cuvettes containing 7 ml synthetic medium,12) which was inoculated with enough log phase Pseudomonas syringiae ATCC 19310 cells to give a turbidometrically-determined concentration of 107 cells per ml. The growth cuvettes were then agitated at 27°C in a biophotometer (Jouan, Paris). At various times (see Fig. 1 ) during the growth period, a 0.2-m1 sample of the cell suspension was withdrawn and then added to 1 ml of cold 7 o trichloroacetic acid. The precipitate formed was collected on a membrane filter (0.45 ft pore size), washed with 5 % trichloroacetic acid, dried, and the radioactivity measured.
3. Protein biosynthesis: Experiments for polyphenylalanine biosynthesis were carried out by a method similar to that of TRAUB et al. The reaction mixture was incubated for 45 minutes at 30°C. The incorporation of radioactivity into hot 5 % trichloroacetic acid-precipitable material was measured by assaying a sample (40 pl) of the reaction mixture by the paper disk method.14)
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Results

The effect of hikizimycin on the incorporation of [14C]-isoleucine and [14C]-uracil by intact cells of Pseudomonas syringiae was determined.
The incorporation of [14C]-thymidine could not be measured, because uptake was insufficient. Hikizimycin reduced isoleucine incorporation within less than 15 minutes after addition, whereas the rate of uracil incorporation remained essentially unchanged during the incubation period after addition of the antibiotic (Fig. 1) . We inferred from these data that the primary action of hikizimycin consists in the inhibition of the protein biosynthesis. This conclusion was further confirmed by the following in vitro experiments.
As shown in Fig. 2 , hikizimycin inhibited the poly U-directed polyphenylalanine biosynthesis in the in vitro system of E. coli completely at the concentration of 10-4 M. Fifty percent inhibition was observed at a ratio of 9 moles of hikizimycin/mole of ribosome. Gougerotin, which was tested in the same system for comparison, inhibited the peptide biosynthesis to the extent of approximately 13 % at the concentration of 10-4 M. However, 50 % inhibition was obtained at a ratio of 2 moles of gougerotin/mole of ribosome. In addition, the effect of hikizimycin on partial reactions in order to locate the sensitive intermediate steps of the peptide chain elongation was studied.
As seen in Table 1 Table 2 ).
The synthesis of N-acetyl-[14C]-phenylalanyl-puromycin is generally considered as a model system of peptidyl transfer reaction. 19) Hikizimycin was found to inhibit this reaction completely at a concentration of 10-4 M.
Gougerotin, when tested in the same system, is less effective as an inhibitor.
The results here reported lead to the following conclusion: hikizimycin interferes with the peptide biosynthesis in the cell-free system from E. coli by affecting the peptidyl transfer reaction. 
